Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2020 | Clinical trials in breast cancer: PALLAS, MONARCH 3 and SOLAR-1

Barbara Pistilli, MD, Institut Gustave Roussy, Villejuif, France, discusses the contradiction between the results of PALLAS (NCT02513394) and MONARCH 3 (NCT02246621) clinical trials. An explanation for the difference could be the more advanced stages of breast cancer involved in MONARCH 3. An analysis is still ongoing to clarify the contradiction in results. Dr Pistilli also discusses the promising results of the SOLAR-1 (NCT02437318) trial which has shown clinical significance. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.